INVITE: CAT SHORT REVIEW/UPDATE TODAY @1PM

Takeaway: Please join us today at 1PM for a review and update on our CAT short thesis. Dial-in and materials below.

INVITE: CAT SHORT REVIEW/UPDATE TODAY @1PM - vf1

 

We will be presenting a flash conference call reviewing our short thesis on Caterpillar Inc. (CAT) titled "Short CAT - What You Need To Know Now" on Thursday, July 18th at 1:00pm EDT. We have published several pieces outlining our short thesis on CAT. After a decade of being a primary beneficiary of the boom in commodity prices CAT may be in a very vulnerable position.

 

 

OBJECTIVE

Detail our short thesis on CAT, why the Company will struggle to meet company targets and street expectations.

 

CALL OVERVIEW 

  • Super-cycle Downside: Resources-related capital spending is likely to decline much more than estimates expect
  • Commodity Markets/Emerging Markets:  Even if emerging markets rebound, which we do not see, commodity supply remains a major headwind
  • Acquisitions:  CAT not only overpaid for ERA and Bucyrus, but also may have benefited from the flexibility in purchase accounting
  • Receivables Growth and Inventories:  High inventories and rapid receivables growth have left CAT with weak free cash flow and other challenges
  • Abandon 2015 Targets?  That would be fast, since they were established in the fall of 2012
  • Valuation:  A low-ish multiple typically means peak earnings, not cheap equity


CALL DETAILS

  • Toll Free Number:  
  • Direct Dial Number:
  • Conference Code: 428976#
  • Materials: CLICK HERE


CONTACT

Please email if you have any questions.


Cartoon of the Day: Crash Test Bear

In the past six months, U.S. stock indices are up between +12% and +18%.

read more

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more